Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TriLink BioTechnologies, Inc. Announces License Agreement with LI-COR Biosciences

Published: Friday, October 19, 2012
Last Updated: Friday, October 19, 2012
Bookmark and Share
TriLink BioTechnologies Inc. (TriLink) announced that it has recently signed a licensing agreement with LI-COR® Biosciences to custom label oligonucleotides, nucleotides, and nucleosides with IRDye® near-infrared dyes.

"This offers our customers a product option that will be more specific to their research, while being based on the IRDye near-infrared dye technology they have grown to trust," says Jim Wiley, LI-COR senior strategic marketing manager. "TriLink has established itself as an expert in the field of modified nucleic acids and we're certain our customers will benefit from this agreement."

LI-COR offers IRDye near-infrared dye technology that delivers enhanced sensitivity due to low background autofluorescence in the near-infrared region and, therefore, higher signal to noise ratios. IRDye near-infrared dyes have absorption and emission wavelengths in the near-infrared spectrum, between 650 nm and 800 nm.

"As experts in modified nucleic acid chemistry and leaders in dye labeling nucleoside triphosphates and oligonucleotides, we are continually expanding our portfolio of available modifications," says Richard Hogrefe, Ph.D., TriLink president and CEO. "The innovative LI-COR infrared dye series, IRDye 650-800, is a perfect fit, opening new doors for our customers seeking enhanced signal-to-noise ratios and dynamic range in applications where autofluorescence is an issue."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TriLink BioTechnologies Announces Agreement with American Cleanroom Systems to build cGMP Facility
Agreement signed to build a 2,000 square foot pharmaceutical cGMP production suite within San Diego facility.
Thursday, October 24, 2013
TriLink Enters into Distribution Agreement with Astral Scientific
The agreement allows Astral to sell Trilink's modified nucleic acid products, including over 150 modified nucleotides, custom oligonucleotides and CleanAmp™ Hot Start PCR Products. The Australian based company supplies clinical diagnostic, life science and industrial markets.
Tuesday, November 15, 2011
TriLink Awarded Phase I Grant for a Second Hot Start PCR Project
TriLink Biotechnologies has received a $100,000 Phase I SBIR grant from the National Institutes of Health, to study an approach to PCR activation.
Tuesday, May 22, 2007
TriLink Awarded Phase II Grant for Start PCR Project
TriLink will optimize protocols for scale up and automated synthesis, in preparation for commercialization of the technology in early 2007.
Thursday, July 27, 2006
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
The Epigenetic Influences of Chronic Pain
Researchers at Drexel University College of Medicine are aiming to identify new molecular mechanisms involved in pain.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!